First Aid Shot Therapy Completes Series B Financing Round

fastFirst Aid Shot Therapy (F.A.S.T.), a Burlingame, California-based consumer healthcare company, completed its Series B financing round.

The round – of undisclosed amount – was co-led by Sofinnova Ventures and Redmile Group with participation support from investors including Sofinnova HealthQuest, Clearwell Group and Mark Rampolla, founder and former CEO of ZICO Beverages.

The company intends to use the funds to bring to market a second product, F.A.S.T. Upset Stomach Relief, and support geographic launches in the Boston area and other major markets nationwide.

Led by Mary Page Platerink, Founder and Chief Executive Officer, First Aid Shot Therapy is a consumer healthcare company focused on over-the-counter (OTC) medicine in liquid “shot” (40ml / 1.35oz.) form, focuses on the development and commercialization of a comprehensive portfolio of OTC pharmaceutical products in liquid “shot” (40ml / 1.35oz.) format, which are formulated by its proprietary research and development organization, F.A.S.T. Labs.



Related News
22/05/2013: First Aid Shot Therapy Completes Series A Financing

Join the discussion